44 research outputs found

    Validity of the French version of the Core Outcome Measures Index for low back pain patients: a prospective cohort study

    Get PDF
    Purpose: Among the many questionnaires available to evaluate low back pain (LBP) patients, the Core Outcome Measures Index (COMI) has the unique advantage to investigate five dimensions using seven short questions. The aim of this study was to explore additional properties of the questionnaire in a French-speaking non-surgical population. Methods: This study was conducted on 168 patients suffering from subacute or chronic LBP and followed up for 6months in three French-speaking countries. In addition to basic psychometric properties (e.g., construct validity, floor and ceiling effect, reproducibility), internal validity was analyzed by a factor analysis using Cronbach's alpha. Responsiveness and sensitivity to change were assessed through minimal detectable change (MDC), effect size, and Minimal Clinically Important Improvement (MCII). We used an anchor-based method with receiver operating characteristic (ROC) curve analysis to assess MCII and the Patient Acceptable Symptom State. Results: Construct validity, reliability (Cronbach's alpha=0.87), reproducibility and the absence of floor and ceiling effects were confirmed. Factor analysis indicated a one-dimensional construct that validates the use of a sum score. The MDC (2.1) was inferior to the MCII (2.3). The limit below which the patient claims to be in a fair condition (Patient Acceptable Symptom State) was set at 3. Conclusions: The COMI is a self-report questionnaire with the capacity to easily and quickly explore several dimensions in patients with LBP that can be then summarized in a meaningful sum score. Additional knowledge provided by our study should encourage the widespread use of the COMI among the spine community

    COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

    Get PDF
    Background: The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms. Methods: International, prospective observational study of 60 109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms. Results: ‘Typical’ symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (≀ 18 years: 69, 48, 23; 85%), older adults (≄ 70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each P < 0.001). The most common atypical presentations under 60 years of age were nausea and vomiting and abdominal pain, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country. Interpretation: This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men

    Former aux défis de la premiÚre ligne

    Full text link
    editorial reviewedBe.hiv

    Mise en Ɠuvre de dispositifs pĂ©dagogiques innovants, utiles aux acteurs de la premiĂšre ligne de soins et d’aide

    No full text
    Parmi les membres de la Chaire Be.Hive, un groupe de chercheurs s’est fixĂ© comme but de recherche de dĂ©crire et comprendre les enjeux, les leviers, les obstacles et les stratĂ©gies des innovateurs aux diffĂ©rents stades de dĂ©veloppement et de mise en Ɠuvre d’un dispositif pĂ©dagogique innovant (DiPI) utile aux acteurs de la premiĂšre ligne de soins et d’aide (PLSA). Pour pouvoir rĂ©pondre Ă  cette question, il parait pertinent :1/ de dĂ©terminer les thĂ©matiques et les caractĂ©ristiques d’un dispositif pĂ©dagogique jugĂ© innovant du point de vue des acteurs professionnels et des bĂ©nĂ©ficiaires des services de la PLSA et 2/ de dĂ©crire et comprendre les enjeux, les leviers, les obstacles et les stratĂ©gies des innovateurs aux diffĂ©rents stades de dĂ©veloppement et de mise en Ɠuvre des dispositifs pĂ©dagogiques co-identifiĂ©s comme innovants par tous les acteurs (enseignants, acteurs professionnels, bĂ©nĂ©ficiaires des services de la premiĂšre ligne de soins et d’aide et chercheurs). En rĂ©pondant successivement Ă  ces questions au travers de diffĂ©rentes sĂ©quences de recherche, les rĂ©sultats des premiĂšres servant de base aux suivantes. L’objectif des chercheurs est de contribuer Ă  la construction d’une communautĂ© d’apprentissage en collectant et en mettant Ă  disposition des enseignants des donnĂ©es pertinentes pour nourrir leurs rĂ©flexions afin de leur permettre de construire des DiPI et pĂ©rennes, qui dĂ©veloppent des savoirs et des compĂ©tences utiles aux acteurs professionnels et aux bĂ©nĂ©ficiaires de services de la PLSA. La programmation de recherche a Ă©tĂ© dĂ©veloppĂ©e de façon heuristique par l’équipe de recherche. Elle recourt Ă  des mĂ©thodes diverses, tant qualitatives que quantitatives. Une premiĂšre sĂ©quence de recherche a permis au moyen d’entretiens de groupes avec les acteurs professionnels de la premiĂšre ligne de soins et d’aide et les bĂ©nĂ©ficiaires :1/ de codĂ©terminer 8 thĂ©matiques jugĂ©es innovantes et 2 / de co-identifier les caractĂ©ristiques d’un dispositif pĂ©dagogique jugĂ© innovant en termes de contenu et de mĂ©thodeinfo:eu-repo/semantics/publishe

    Former aux défis de la premiÚre ligne

    No full text
    info:eu-repo/semantics/publishe

    Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts

    No full text
    International audienceBackground: Severely ill patients with SARS-CoV-2 have an increased risk of venous thromboembolism (VTE) i.e., deep vein thrombosis and pulmonary embolism. However, the VTE risk in patients with mild and moderate COVID-19, hospitalized or managed at home, remain uncertain. The aims of this study were to assess the rate and the risk factors symptomatic VTE, in patients with mild and moderate COVID-19 and to compare them to a cohort of similar patients without COVID-19. Methods: Patients presenting to the emergency department (ED) of participating centers for confirmed or probable mild or moderate COVID-19 and not having acute VTE were included. This COVID-19 cohort was retrospectively compared to a prospective cohort of similar ED patients using propensity score matching. The main outcome was the rate of symptomatic VTE within the 28 days after ED presentation. Results: A total of 2292 patients were included in the COVID-19 cohort. The 28-day incidence of symptomatic VTE was 1.3% (n = 29/2292, 95%CI: 0.9 to 1.8), 2.3% (n = 20/866, 95%CI: 1.5 to 3.5) in moderate COVID-19 patients and 0.6% (n = 9/1426; 95%CI: 0.3 to 1.2) in mild COVID-19 patients managed as outpatients. An age over 65 years and hospitalization were independent risk factors of VTE. After adjustment, patients in the COVID19 cohort had an absolute increase in over symptomatic VTE risk of +1.69% (95%CI, 0.88 to 2.51) versus patients in the comparison cohort (n = 1539). Conclusions: Patients with moderate COVID-19 presenting to the ED had a high risk of subsequent VTE. Trial registration: Ethics committee of the CHU of Angers (N degrees 2020/87)
    corecore